China's genetic testing group Mega Genomics shines in Hong Kong debut

Mega Genomics

22/06/2022 04:54

** Shares of Chinese genetic testing and cancer screening
services provider Mega Genomics Ltd  6667.HK  trade as high as
HK$21 ($2.68) each in Hong Kong debut on Wednesday, up 16.7%
from their offer price
    ** Stock last trade HK$18.76, 4.2% above their IPO price of
HK$18 apiece
    ** Beijing-based company issued 11.96 mln shares in its 
global offering, raising HK$215.3 mln ($27.43 mln) for
commercialization of its services, to fund research and
development and for expanding its testing capacity  urn:newsml:reuters.com:*:nFWN2Y7071
    ** Three cornerstone investors are Nanchang Financial,
Nanchang Industrial Park and Maccura Biotechnology  300463.SZ 
    ** Hang Seng Commerce & Industry Index  .HSNC  drops 1.9%,
healthcare index  .HSCIH  slips 1%, and the benchmark Hang Seng
Index  .HSI  falls 1.3%


($1 = 7.8499 Hong Kong dollars)

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))